Celldex Therapeutics Inc. (CLDX) Insider Trading

Last 12 months

Insiders sold $121k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. SVP & GENERAL COUNSEL Freddy A. Jimenez sold $121k on Dec 4, 2025, 12% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2024.

Net open-market

−$121k

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Nov 2024

Nov 11, 2024

Get an email when CLDX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Dec 4, 2025	Freddy A. Jimenez SVP & GENERAL COUNSEL	SoldNo plan	4,166	$29.10	$121k	12%	Form 4
Nov 13, 2025	Richard M. Wright Other	SoldNo plan	49,298	$24.00	$1.18M	70%	Form 4
Aug 13, 2025	Freddy A. Jimenez SVP & GENERAL COUNSEL	SoldNo plan 2 parts	771	$24.77 average	$19k	2.2%	Form 4
Nov 11, 2024	Anthony S Marucci PRESIDENT & CEO	Bought	11,500	$26.82	$308k	40%	Form 4

Dec 4, 2025No plan
Freddy A. Jimenez
SVP & GENERAL COUNSEL · sold 4,166 at $29.10
$121k
12% of stake
Nov 13, 2025No plan
Richard M. Wright
Other · sold 49,298 at $24.00
$1.18M
70% of stake
Aug 13, 2025No plan
Freddy A. Jimenez
SVP & GENERAL COUNSEL · sold 771 at avg $24.77
$19k
2.2% of stake
Nov 11, 2024
Anthony S Marucci
PRESIDENT & CEO · bought 11,500 at $26.82
$308k
40% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CLDX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: In Vitro & In Vivo Diagnostic Substances

AWHLAspira Women's Health Inc.

PLPLPlandai Biotechnology Inc.

SERSerina Therapeutics Inc.

HINDVyome Holdings, Inc

CFOOChina Foods Holdings Ltd.

ATYRAtyr Pharma Inc.

BIXTBioxytran Inc.

LEXXLexaria Bioscience Corp.

Spot a number that looks wrong? Check it in CLDX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CLDX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.